Client News

Abivax Publishes Review in Drug Discovery Today on Mechanism of Action and Transformative Potential of ABX464 as Therapy for Inflammatory Diseases

ViGeneron signs global collaboration agreement for ophthalmic gene therapy development

Adrenomed AG: Adrenomed Supervisory Board appoints Dr. Wolfgang Baiker as CEO

RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib

4basebio AG announces changes to the Management Board

Abivax’s Covid-19 Phase 2b/3 miR-AGE trial with ABX464 declared Research National Priority by the French government’s Clinical Trial Council

Apogenix AG – COVID-19: targeted treatment trial launched in Vienna

Adocia announces its financial calendar for 2021

Abivax to present at the 39th Annual J.P. Morgan Healthcare Conference ahead of major clinical milestones

Allecra Therapeutics and Shanghai Haini Pharmaceutical Announce Exclusive Licensing Agreement for Cefepime/enmetazobactam for Greater China